A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant
Clinical trial NCT06514742 · TERMINATED
Trial details
- NCT number
- NCT06514742
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-26
- Primary completion
- 2025-04-08
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.